Collectively, these data suggest that TREX1 depletion in chemoresistant SCLC cells contributes to the induction of a tumor intrinsic innate immune response by activating the cGAS-STING pathway, which senses chemotherapy-derived dsDNA aberrantly accumulated in the cytoplasm. The gene discussed is TREX1; the disease is neoplasm.